Skip to content

Clinical trials

Phase 3 Hypertension, Pulmonary trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 3 Country / region: Mexico Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20061
20084
20094
20121
20141
20151
20161
20171
20192
20201
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting2
Enrolling by invitation1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
United Therapeutics5
Biogen2
Pfizer2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Actelion1
Eli Lilly and Company1
Gilead Sciences1
Insmed Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary21
Pulmonary Arterial Hypertension13
Cardiovascular Diseases2
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Hypertension2
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2
Lung Diseases, Interstitial1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.